Feb 2 (Reuters) - ANNOUNCES A NON- RENOUNCEABLE RIGHTS ISSUE OF ONE NEW SHARE FOR EVERY EIGHT SHARES TO RAISE UP TO APPROXIMATELY A$3.38 MILLION AT A$0.13 PER SHARE [ ]
Webinar: What investors should know about what it takes for ASX-listed companies to get medical developments to market